Xiamen-based company making molecular diagnostic kits and sequencing tools for cancer and genetic disease testing.
Xiamen SpaceGen Co., Ltd., trading as SPACEGEN, was established in 2015 in Xiamen, China, and offers cancer, genetic disease and precision medical testing through R and D, production, sales and advisory services. It has developed more than 50 molecular diagnostic products, nearly 30 of them CE-IVD approved, and sells its IVD products in more than 30 countries and regions. In February 2026 the company received strategic investment from Shanghai Yinyu Investment Management Center and Autobio Diagnostics Co., Ltd.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in